Back to search

University of Ioannina

Αποτίμηση θεραπευτικών παρεμβάσεων σε παιδιατρικούς καρκίνους με έμφαση στο ρετινοβλάστωμα

Abstract

dc:description

Therapeutic advancements have substantially improved childhood cancer prognosis. However, the strength of the supporting evidence has not yet been thoroughly evaluated. The main scopes of the present doctoral dissertation were to assess the robustness and validity of the existing evidence, particularly from randomized controlled trials (RCTs), and to identify potential knowledge gaps while proposing recommendations to enrich the literature in this scientific field. The dissertation comprises four distinct research projects. The initial section includes two umbrella reviews aimed at providing an overview of therapeutic and supportive interventions for pediatric malignancies. The subsequent part places specific emphasis on retinoblastoma, the most common primary intraocular tumor in childhood, with two systematic reviews, one of which encompasses all RCTs related to the disease, while the other focuses on intravitreal chemotherapy, a relatively recent addition to the armamentarium of disease management that has revolutionized the approach to dealing with vitreous seeding. In the first umbrella review, aiming to critically appraise the randomized evidence on therapeutic interventions for childhood cancer, 14 publications reporting 68 individual meta-analyses with 31,496 participants in total were included. Most of them focused on acute lymphoblastic leukemia, with the most robust evidence indicating increased disease-free survival with methotrexate and vincristine/prednisone pulses. Evidence regarding other cancer types was relatively weak, with most meta-analyses being small, involving a median of 3 RCTs and 784.5 participants per comparison. Because of inherent difficulties in conducting randomized trials in pediatric populations, let alone for a rare disease like childhood cancer, most of the evidence pertaining to treatment safety and efficacy is derived from small individual RCTs and early-phase trials, with adult studies providing valuable indirect evidence. While acknowledging the value of these sources, we believe that larger RCTs and their subsequent meta-analyses, possibly through international collaborations, will aid decision-making and increase certainty and precision in delivering effective care to young patients. Our focus then shifted towards supportive interventions, which are gaining increasing importance as the prognosis of the disease improves, resulting in a growing population of pediatric cancer patients and survivors that face treatment-related morbidity, pain, and psychological burden. A total of 34 articles, including 92 individual meta-analyses and one network meta-analysis, involving a total of 14,521 participants, were included in the umbrella review that was conducted. Particular interest seems to exist in recent years regarding non-pharmacological interventions, with hypnosis reducing pain and anxiety related to anticancer treatment, and exercise interventions improving the functional mobility of patients. As for pharmacological interventions, most of the studies pertained to the management of chemotherapy-induced nausea and vomiting, infections, and febrile neutropenia. Similarly to therapeutic interventions, most meta-analyses on supportive interventions were small, and approximately one-third of them exhibited significant heterogeneity, underscoring the importance of enhancing the available evidence. Subsequently, emphasis was placed on retinoblastoma, the prognosis of which has markedly improved in recent decades, rendering it one of the pediatric cancers with the highest survival rates when diagnosed early. However, prognosis varies significantly between high-income and low-income countries, globe salvage and vision preservation remain challenging, and treatment-related morbidity requires careful management. Only four RCTs with a total of 188 eyes have been conducted for the disease, all pertaining to protocols of intravenous chemotherapy. The combination of vincristine, etoposide, and carboplatin at standard dosages appears to offer the optimal tumor control with a relatively good safety profile and is now the most frequently used chemotherapy regimen worldwide. Modern therapeutic approaches, particularly targeted chemotherapy, primarily rely on observational studies and early-phase clinical trials. Intravitreal chemotherapy involves the targeted injection of chemotherapeutic agents into the vitreous. Its use as a salvage therapy, particularly in eyes with persistent or recurrent vitreous seeding after primary intravenous or intraarterial chemotherapy, appears to increase globe salvage rates in eyes otherwise at risk of enucleation, reaching up to 100% in some clinical series. However, treatment complications, including cataract, retinal toxicity, and vitreous hemorrhage, necessitate careful management. Nevertheless, serious and permanent adverse effects appear to be limited, while the risk of extraocular dissemination, a significant concern, is almost eliminated through preventive techniques. Nonetheless, the systematic review conducted revealed that most relevant studies are retrospective, and there are no RCTs, with implications for risk of bias and the strength of the evidence in the field. In any case, whether considering intravitreal chemotherapy or other treatment options, conducting multicenter randomized studies through international collaborations of specialized centers can significantly enhance the available information. Overall, this doctoral dissertation critically evaluated the evidence regarding the efficacy and safety of therapeutic and supportive interventions for pediatric cancer, with a particular focus on retinoblastoma, underscoring the relatively limited information derived from RCTs. Despite the significant progress made in recent decades, leading to a remarkable improvement in childhood cancer prognosis, it is certain that strengthening and expanding the available information will contribute to even better quality of care for young patients.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Lavasidis, Georgios
  • Λαβασίδης, Γεώργιος

Subjects

dc:subject × 26

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/56536

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Lavasidis, Georgios; Λαβασίδης, Γεώργιος. Αποτίμηση θεραπευτικών παρεμβάσεων σε παιδιατρικούς καρκίνους με έμφαση στο ρετινοβλάστωμα. University of Ioannina, 2024. http://hdl.handle.net/10442/hedi/56536